Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination

Heterologous SARS-CoV-2 vaccine approaches with a second mRNA-based vaccine have been favored in the recommendations of many countries over homologous vector-based ChAdOx1 nCoV-19 vaccination after reports of thromboembolic events and lower efficacy of this regimen. In the middle of 2021, the SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauswein, Markus, Peterhoff, David, Plentz, Annelie, Hiergeist, Andreas, Wagner, Ralf, Gessner, André, Salzberger, Bernd, Schmidt, Barbara, Bauernfeind, Stilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730691/
https://www.ncbi.nlm.nih.gov/pubmed/35013723
http://dx.doi.org/10.1016/j.isci.2021.103694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730691/
https://www.ncbi.nlm.nih.gov/pubmed/35013723
http://dx.doi.org/10.1016/j.isci.2021.103694

Ejemplares similares